Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
146.14
+2.18 (1.51%)
Aug 20, 2025, 3:21 PM - Market open
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $4.23 billion as of August 20, 2025. Its market cap has decreased by -22.84% in one year.
Market Cap
4.23B
Enterprise Value
3.35B
1-Year Change
-22.84%
Ranking
Category
Stock Price
$146.14
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $102.60M to $4.23B, an increase of 4,022.37%. That is a compound annual growth rate of 59.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 4.17B | -7.52% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 17.08% |
| Dec 31, 2021 | 1.74B | 47.34% |
| Dec 31, 2020 | 1.18B | 23.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.52B |
| Johnson & Johnson | 425.41B |
| AbbVie | 365.13B |
| UnitedHealth Group | 275.33B |
| AstraZeneca | 243.89B |
| Novartis AG | 239.15B |
| Abbott Laboratories | 229.31B |
| Novo Nordisk | 227.24B |